Department of Pathology, School of Veterinary Medicine, Shiraz University, Shiraz, Iran.
Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
J Biomed Mater Res B Appl Biomater. 2019 Jan;107(1):50-64. doi: 10.1002/jbm.b.34094. Epub 2018 Feb 21.
Critical-sized bone defects constitute a major health issue in orthopedics and usually cause mal-unions due to an inadequate number of migrated progenitor cells into the defect site or their incomplete differentiation into osteogenic precursor cells. The current study aimed to develop an optimized osteoinductive and angiogenic scaffold by incorporation of strontium (Sr) and bioglass (BG) into gelatin/nano-hydroxyapatite (G/nHAp) seeded with bone marrow mesenchymal stem cells to enhance bone regeneration. The scaffolds were fabricated by a freeze-drying technique and characterized in terms of morphology, structure, porosity and degradation rate. The effect of fabricated scaffolds on cell viability, attachment and differentiation into osteoblastic lineages was evaluated under in vitro condition. Micro computed tomography scan, histological and histomorphometric analysis were performed after implantation of scaffolds into the radial bone defects in rat. RT-PCR analysis showed that G/nHAp/BG/Sr scaffold significantly increased the expression level of osteogenic and angiogenic markers in comparison to other groups (P < 0.05). Moreover, the defects treated with the BMSCs-seeded scaffolds showed superior bone formation and mechanical properties compared to the cell-free scaffolds 4 and 12 weeks post-implantation. Finally, the BMSCs-seeded G/nHAp/BG/Sr scaffold showed the greatest bone regenerative capacity which was more similar to autograft. It is concluded that combination of Sr, BG, and nHAp can synergistically enhance the bone regeneration process. In addition, our results demonstrated that the BMSCs have the potential to considerably increase the bone regeneration ability of osteoinductive scaffolds. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 107B: 50-64, 2019.
临界尺寸骨缺损是矫形外科的一个主要健康问题,通常由于迁移祖细胞进入缺损部位的数量不足或其不完全分化为成骨前体细胞而导致畸形愈合。本研究旨在通过将锶(Sr)和生物玻璃(BG)掺入到载骨髓间充质干细胞的明胶/纳米羟基磷灰石(G/nHAp)中,开发一种优化的成骨诱导和血管生成支架,以增强骨再生。支架采用冷冻干燥技术制备,并在形态、结构、孔隙率和降解率方面进行了表征。在体外条件下,评估了制备的支架对细胞活力、附着和向成骨谱系分化的影响。在大鼠桡骨缺损中植入支架后进行微计算机断层扫描、组织学和组织形态计量学分析。RT-PCR 分析显示,与其他组相比,G/nHAp/BG/Sr 支架显著增加了成骨和血管生成标志物的表达水平(P < 0.05)。此外,与无细胞支架相比,负载 BMSCs 的支架在植入后 4 和 12 周时显示出更好的骨形成和机械性能。最后,负载 BMSCs 的 G/nHAp/BG/Sr 支架显示出最强的骨再生能力,与自体移植物更为相似。结论是,Sr、BG 和 nHAp 的组合可以协同增强骨再生过程。此外,我们的结果表明,BMSCs 具有显著提高成骨诱导支架骨再生能力的潜力。2018 年 Wiley 期刊公司。J 生物医学材料研究 B:应用生物材料,107B:50-64,2019 年。